Advertisement
U.S. Markets open in 8 hrs 42 mins

Gain Therapeutics, Inc. (GANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
2.2300-0.0400 (-1.76%)
At close: 04:00PM EST
2.2700 +0.04 (+1.79%)
After hours: 04:20PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close2.2700
Open2.2900
Bid2.1900 x 200
Ask2.2500 x 200
Day's Range2.1920 - 2.3400
52 Week Range0.8900 - 5.3300
Volume165,107
Avg. Volume411,877
Market Cap56.944M
Beta (5Y Monthly)0.34
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Clinical Trials Arena

    Gain Therapeutics reports positive data from Phase I Parkinson’s treatment trial

    In the trial, GT-02287 was found to be safe and well-tolerated at all dose levels, including the highest planned doses.

  • InvestorPlace

    7 Sorry Biotech Stocks Set to Make Investors Sad

    Biotech stocks are not for everyone, let’s make that perfectly clear. It’s challenging to invest in a field in which companies – particularly startups – can go for years without seeing a penny of revenue. While there are several outstanding companies from which to choose, the field is also littered with biotech stocks to sell before you get into too much trouble. Biotech stocks represent companies that are in the medical field. They develop and commercialize new medical treatments, drugs, and te